Breaking news on cholesterol
Statins Work As Well On Females As Males published
Tue, 31 Jan 2012 12:00:00 PST
Statins given to female patients are as effective in preventing the occurrence of cardiovascular events as they are for men, researchers from Boston and New York reported in the Journal of the American College of Cardiology. Cardiovascular events include stroke, heart attack, and angina. William J. Kostis, Ph.D., M.D...
Study Of Genetic Regulation Of Metabolomic Biomarkers - Paths To Cardiovascular Diseases And Type 2 Diabetes published
Mon, 30 Jan 2012 01:00:00 PST
In a study into the genetic variance of human metabolism, researchers have identified thirty one regions of the genome that were associated with levels of circulating metabolites, i.e., small molecules that take part in various chemical reactions of human body...
Identification Of Entry Point For Hepatitis C Infection published
Thu, 26 Jan 2012 00:00:00 PST
A molecule embedded in the membrane of human liver cells that aids in cholesterol absorption also allows the entry of hepatitis C virus, the first step in hepatitis C infection, according to research at the University of Illinois at Chicago College of Medicine...
Statins May Work Against Certain Breast Cancers published
Mon, 23 Jan 2012 02:00:00 PST
Statins are commonly prescribed to lower cholesterol, but a recent study suggest certain types of breast cancer may respond to treatment with statins...
A Biomarker Test For Atherosclerosis To Seek Out The Silent Killer published
Sat, 14 Jan 2012 00:00:00 PST
Furring of the arteries, atherosclerosis, is a leading cause of death across the world. Atherosclerosis leads to peripheral arterial disease, coronary heart disease, stroke and heart attacks. However, atherosclerosis is a sneaky killer - most people do not realize they have it until they have cardiovascular disease (CV)...
Novel Target In Artery Plaque Discovered As Potential Therapeutic Intervention published
Tue, 10 Jan 2012 03:00:00 PST
A new study by NYU Langone Medical Center researchers identified a new culprit that leads to atherosclerosis, the accumulation of fat and cholesterol that hardens into plaque and narrows arteries. The research, published online by Nature Immunology on January 8, 2012, explains why cholesterol-laden, coronary artery disease-causing cells called macrophages, accumulate in artery plaques...
Benefits Of Statin Therapy May Extend Beyond Lowering Lipids published
Fri, 06 Jan 2012 00:00:00 PST
People with high cholesterol are at risk of heart attack and stroke because atherosclerotic plaques within their arteries can rupture triggering the formation of a blood clot called an occlusive thrombus that cuts off the blood supply to their heart or brain. For years, scientists have studied the cause of this abnormal clotting...
As Part Of A Heart-Healthy Diet, Eating Lean Beef Daily Can Help Lower Cholesterol published
Wed, 28 Dec 2011 00:00:00 PST
A new study published in the January 2012 edition of American Journal of Clinical Nutrition shows that beef can play a role in a cholesterol-lowering diet, despite commonly held beliefs. The study found that diets including lean beef every day are as effective in lowering total and LDL "bad" cholesterol as the "gold standard" of heart-healthy diets (DASH, Dietary Approaches to Stop Hypertension)...
Cholesterol-Lowering Drugs May Reduce Mortality For Influenza Patients published
Sat, 17 Dec 2011 02:00:00 PST
Statins, traditionally known as cholesterol-lowering drugs, may reduce mortality among patients hospitalized with influenza, according to a new study released online by The Journal of Infectious Diseases...
Cholesterol-Lowering Medication Accelerates Depletion Of Plaque In Arteries published
Wed, 14 Dec 2011 02:00:00 PST
In a new study, NYU Langone Medical Center researchers have discovered how cholesterol-lowering drugs called statins promote the breakdown of plaque in the arteries. The study was published online by the journal PLoS One on December 6, 2011...
Agent Responsible For Protection Against Early Stages Of Atherosclerosis Identified published
Wed, 14 Dec 2011 01:00:00 PST
Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in fat and cholesterol. The findings, which appear on-line in Circulation, may have significant public health implications...
Low-Density Lipoprotein Treatment Breakthrough published
Mon, 12 Dec 2011 09:00:00 PST
A novel breakthrough advance in fighting low-density lipoprotein (LDL) or "bad" cholesterol in the body has been announced by investigators from the University of Leicester and University of California Los Angeles (UCLA). The universities have filed two patents in order to develop targeted medications designed to lower levels of LDL...
New Advance Announced In Reducing 'Bad' Cholesterol published
Sat, 10 Dec 2011 00:00:00 PST
Scientists from the University of Leicester and the University of California Los Angeles (UCLA) have announced a major advance towards developing drugs to tackle dangerous, or 'bad', cholesterol in the body. They have filed two patents for developing targeted drugs that would act as a catalyst for lowering levels of 'bad' cholesterol...
Potential Breast Cancer Prevention Agent Found To Lower Levels Of 'Good' Cholesterol Over Time published
Sat, 10 Dec 2011 00:00:00 PST
Exemestane steadily lowered levels of "good" cholesterol in women taking the agent as part of a breast cancer prevention study, say researchers at Georgetown Lombardi Comprehensive Cancer Center. Exemestane, an aromatase inhibitor used to treat estrogen receptor-positive breast cancer, is being tested to prevent breast cancer in women at an increased risk of developing the disease...
New Advance Announced In Reducing 'bad' Cholesterol published
Sat, 10 Dec 2011 00:00:00 PST
Scientists from the University of Leicester and the University of California Los Angeles (UCLA) have announced a major advance towards developing drugs to tackle dangerous, or 'bad', cholesterol in the body. They have filed two patents for developing targeted drugs that would act as a catalyst for lowering levels of 'bad' cholesterol...
New Advance Announced In Reducing 'bad' Cholesterol published
Fri, 09 Dec 2011 02:00:00 PST
Scientists from the University of Leicester and the University of California Los Angeles (UCLA) have announced a major advance towards developing drugs to tackle dangerous, or 'bad', cholesterol in the body. They have filed two patents for developing targeted drugs that would act as a catalyst for lowering levels of 'bad' cholesterol...
Preventing Atherosclerosis published
Fri, 09 Dec 2011 01:00:00 PST
By changing the behavior of certain cells within human blood vessels, Cornell University researchers have discovered important clues as to the underlying causes of atherosclerosis - a discovery researchers hope can lead to more targeted drug therapies for the prevention of the disease...
Gene Mutation Allows You To Have Your Cream And Eat It, Too published
Wed, 07 Dec 2011 01:00:00 PST
People who carry a malfunctioning copy of a particular gene are especially good at clearing fat from their systems. The report in the December Cell Metabolism, a Cell Press publication, shows how the mutant gene influences metabolism in this way...
End Of The Road For Pfizer's Lipitor published
Thu, 01 Dec 2011 19:00:00 PST
The FDA approved today a generic version of Pfizer's Lipitor, one of the world's best selling drugs. Known pharmaceutically as atorvastatin calcium tablets, Lipitor is used to reduce cholesterol. The generic version will be manufactured by Ohm Laboratories in New Brunswick, N.J. Cholesterol itself is not a major problem and is, in fact, an essential nutrient for the body...
Cholesterol-Lowering Lipitor: FDA Okays First Generic Version published
Thu, 01 Dec 2011 03:00:00 PST
The US Food and Drug Administration (FDA) announced on Wednesday that it has approved the first generic version of the world's top-selling medicine, the cholesterol-lowering drug Lipitor (atorvastatin), currently marketed by Pfizer Inc...
Cholesterol Levels And Heart Disease Biomarkers In Diabetics Improved By Vitamin D-Fortified Yoghurt published
Sun, 27 Nov 2011 00:00:00 PST
People with diabetes are known to have an increased risk of heart disease. New research published in BioMed Central's open access journal BMC Medicine shows that regular consumption of a vitamin D-fortified yoghurt drink improves cholesterol levels and biomarkers of endothelial dysfunction, a precursor of heart disease, in diabetics...
Vascular Lipid Accumulation Seen In Young Transparent Zebrafish published
Wed, 23 Nov 2011 00:00:00 PST
A study using genetically modified zebrafish to visualize early events involved in development of human atherosclerosis describes an efficient model - one that the researchers say offers many applications for testing the potential effectiveness of new antioxidant and dietary therapies...
Possible New Target For Atherosclerosis Treatment - Hormone That Controls Iron Levels published
Fri, 18 Nov 2011 01:00:00 PST
Researchers at Emory University School of Medicine have identified hepcidin, a hormone that regulates iron levels in the body, as a potential target for treating atherosclerosis. Suppressing hepcidin is a way to reduce the iron levels inside the white blood cells found in arterial plaques...
New Research May Provide Clues Into The Molecular Links Between Psoriasis And Heart Disease published
Fri, 18 Nov 2011 01:00:00 PST
Collaborative research from Perelman School of Medicine at the University of Pennsylvania has shown that psoriasis patients have an increased risk of heart attack, stroke and cardiovascular death, especially if the psoriasis is moderate to severe. Now, Penn researchers have discovered the potential underlying mechanism by which the inflammatory skin disease impacts cardiovascular health...
Niacin Does Not Reduce Heart Attack, Stroke Risk In Stable, Cardiovascular Patients Whose Cholesterol Is Well-Controlled To Treatment Guidelines published
Fri, 18 Nov 2011 00:00:00 PST
At the American Heart Association meeting, UB professor of medicine William E. Boden, MD, discussed the AIM-HIGH clinical trial, which found that niacin provides no incremental benefit to patients with atherosclerotic heart disease, whose levels of LDL cholesterol and non-HDL (which contributes to plaque in the arteries) were very well-controlled...
)
|
|
